Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;36(4):739-742.
doi: 10.1093/ndt/gfaa310.

Glucocorticoid-free treatment of severe ANCA-associated vasculitis

Tariq E Farrah  1   2 , Maria Prendecki  3   4 , Robert W Hunter  1   2 , Rashmi Lahiri  2 , Thomas D Cairns  4 , Charles D Pusey  3   4 , Stephen P McAdoo  3   4 , Neeraj Dhaun  1   2
Affiliations

Glucocorticoid-free treatment of severe ANCA-associated vasculitis

Tariq E Farrah et al. Nephrol Dial Transplant. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

All authors declare no conflicts of interest related to the submitted work.

Figures

Figure 1
Figure 1. Renal histopathology (Patient 7) and imaging findings (Patient 9) before and after treatment.
(A) Area of perivascular granulomatous inflammation and early cellular crescent formation in a glomerulus with periglomerular interstitial inflammatory cell infiltrate (× 100). (B) Post-treatment biopsy demonstrating resolution of interstitial and vascular inflammation (× 40). (C and D) Computed tomographs of the thorax. (C) Pretreatment findings of bi-apical cavities and left lower lobe nodules. (D) There was a significant reduction in nodule size after treatment, so only a small area of residual scarring was evident on the follow-up scans obtained after 3 months.
See this image and copyright information in PMC

References

    1. Watts RA, Mooney J, Skinner J, et al. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener’s) and microscopic polyangiitis. Rheumatology. 2012;51:926–931. - PMC - PubMed
    1. Little MA, Nightingale P, Verburgh CA, et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann RheumDis. 2010;69:1036–1043. - PubMed
    1. McGovern D, Williams SP, Parsons K, et al. Long-term outcomes in elderly patients with ANCA-associated vasculitis. Rheumatology. 2020;59:1076–1083. - PMC - PubMed
    1. de Groot K, Harper L, Jayne DR, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150:670–680. - PubMed
    1. Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–232. - PMC - PubMed